Variable | All patients (n = 268) | Without warfarin (n = 180) | ||||
---|---|---|---|---|---|---|
HR | 95% CI | P value | HR | 95% CI | P value | |
CHA2DS2-VASc score (↑ per unit) | ||||||
Crude | ||||||
CHA2DS2-VASc | 1.28 | 1.08–1.53 | 0.006 | 1.11 | 0.90–1.37 | 0.32 |
Multivariable models | ||||||
1. Crude +Hb + Co-morbidity index | 1.66 | 1.22–2.28 | 0.001 | 1.32 | 0.90–1.92 | 0.16 |
2. 1 + Time since AF diagnosis + Kt/V + A-V access thrombosis in the past | 1.73 | 1.23–2.45 | 0.002 | 1.22 | 0.81–1.85 | 0.34 |
3. 2 + All-cause death | 1.74 | 1.23–2.46 | 0.002 | 1.22 | 0.81–1.84 | 0.35 |
CHA2DS2-VASc score (≥6) | ||||||
Crude | ||||||
CHA2DS2-VASc | 2.75 | 1.43–5.31 | 0.003 | 2.61 | 1.14–5.94 | 0.02 |
Multivariable models | ||||||
1. Crude + Hb + Co-morbidity index | 5.81 | 2.04–16.60 | 0.001 | 6.03 | 1.51–24.05 | 0.01 |
2. 1 + Time since AF diagnosis + Kt/V + A-V access thrombosis in the past | 5.56 | 1.89–16.36 | 0.002 | 4.92 | 1.09–22.22 | 0.04 |
3. 2 + All-cause death | 5.57 | 1.88–16.49 | 0.002 | 5.00 | 1.09–22.88 | 0.04 |
Prior stroke and/or TIA | ||||||
Crude | ||||||
prior stroke and/or TIA (yes) | 3.44 | 1.78–6.65 | < 0.001 | 2.63 | 1.56–5.97 | 0.02 |
Multivariable models | ||||||
1. Crude +Hb + Co-morbidity index | 8.55 | 2.93–24.97 | < 0.001 | 8.86 | 1.95–40.36 | 0.005 |
2. 1 + Time since AF diagnosis + Kt/V + A-V access thrombosis in the past | 8.64 | 2.83–26.36 | < 0.001 | 8.21 | 1.64–40.95 | 0.01 |
3. 2 + All-cause death | 8.65 | 2.82–26.49 | < 0.001 | 8.23 | 1.65–41.16 | 0.01 |